| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.35 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 6e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.2 |